Passive and iontophoretic transdermal penetration of methotrexate.
about
Methotrexate for topical application in an extemporaneous preparation.Drug delivery and formulations for the topical treatment of psoriasis.Iontophoresis: a potential emergence of a transdermal drug delivery system.Study of magnetic silk fibroin nanoparticles for massage-like transdermal drug delivery.Diagnostic and therapeutic applications of iontophoresis.Progress in Psoriasis Therapy via Novel Drug Delivery Systems.Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.Biophysical assessment of DC iontophoresis and current density on transdermal permeation of methotrexate.Iontophoretic permeation of lisinopril at different current densities and drug concentrations.Formulation and in vitro evaluation of ufasomes for dermal administration of methotrexate.Studies on in vitro and in vivo transdermal flux enhancement of methotrexate by a combinational approach in comparison to oral delivery.Iontophoretic delivery of lisinopril: Optimization of process variables by Box-Behnken statistical design.Potential for methotrexate exposure through contamination during parenteral use as an immunosuppressant.Transdermal penetration of diclofenac in the presence of AAPH-derived peroxyl radicals.Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.Iontophoretic drug delivery using the IOMED Phoresor system.Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skinElectrically and Ultrasonically Enhanced Transdermal Delivery of Methotrexate
P2860
Q30316265-2D9A148A-8A21-4D9D-8EA0-928153F7313DQ33318104-6B569CD2-72E6-4598-8C25-CEDB328C8E1FQ34259364-2F77B627-AF02-4C90-9933-1733D2BB3786Q35892638-ABAF4BEB-CE1C-456B-8A36-D3C0ADDF0788Q37618810-9203C66F-ECAE-4027-9F99-3A5C766BDC37Q38266900-CEEA9F7B-C9D3-40A0-9CEA-AB4382A9443CQ38850032-46B54927-409C-4BF5-83A4-5E5D2A23291DQ41894186-5D5F27A0-2A92-48F4-B0DE-C9C47D1A54CAQ41946869-95A094C3-01C6-4159-ADD2-356C64366BF7Q42084988-4FCCFC55-50C7-43FB-B130-7DD3E82DC356Q43260825-90C9BEE3-B939-4F2E-ACE9-8D1CEDD0DBF4Q45935470-1F12C4BE-C023-427A-826D-7439DD780223Q45938296-890ABA84-4E78-4DFA-9535-D5CF37B4EAC5Q46054291-D938CC01-E341-4DD9-8EDC-562167746F91Q46844120-5847775C-A504-4767-92A1-5BB4A30AA128Q48754903-2DB70CED-7FFB-45CF-801D-99E1AF55EA38Q50913374-ACE181A1-ACF0-4F6D-B4C2-A3AAC234ECE5Q58493984-5E05FB3F-D748-45AB-B0BD-6D397DF7EEFBQ58799952-D8A37F20-2BE6-4CF6-A97F-479106733506
P2860
Passive and iontophoretic transdermal penetration of methotrexate.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Passive and iontophoretic transdermal penetration of methotrexate.
@ast
Passive and iontophoretic transdermal penetration of methotrexate.
@en
type
label
Passive and iontophoretic transdermal penetration of methotrexate.
@ast
Passive and iontophoretic transdermal penetration of methotrexate.
@en
prefLabel
Passive and iontophoretic transdermal penetration of methotrexate.
@ast
Passive and iontophoretic transdermal penetration of methotrexate.
@en
P1476
Passive and iontophoretic transdermal penetration of methotrexate
@en
P2093
M J Alvarez-Figueroa
P304
P356
10.1016/S0378-5173(00)00599-8
P407
P577
2001-01-01T00:00:00Z